We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
1076
DELISTED
Molecular Templates, Inc.
MTEM
| $1.56M | ﹤0.01% |
7,567
+4,026
| +114% | +$935K |
|
1077
Helen of Troy
HELE
$641M
| $1.56M | ﹤0.01% |
8,292
-538
| -6% | -$88.1K |
|
1078
Red Rock Resorts
RRR
$3.12B
| $1.54M | ﹤0.01% |
140,930
+2,780
| +2% | +$31.4K |
|
1079
Boeing
BA
$156B
| $1.52M | ﹤0.01% |
8,316
+2,354
| +39% | +$362K |
|
1080
EastGroup Properties
EGP
$10.8B
| $1.52M | ﹤0.01% |
12,827
-182,073
| -93% | -$20.1M |
|
1081
Arrowhead Research
ARWR
$9.57B
| $1.51M | ﹤0.01% |
35,030
-159,678
| -82% | -$5.64M |
|
|
SPTN
1082
DELISTED
SpartanNash
SPTN
| $1.51M | ﹤0.01% |
71,141
+21,096
| +42% | +$379K |
|
1083
Peloton Interactive
PTON
$2.15B
| $1.5M | ﹤0.01% |
+26,012
| New | +$1.08M |
|
1084
Avantor
AVTR
$10.7B
| $1.5M | ﹤0.01% |
87,945
+22,113
| +34% | +$360K |
|
1085
Simulations Plus
SLP
$373M
| $1.49M | ﹤0.01% |
24,943
-97
| -0.4% | -$4.27K |
|
1086
Henry Schein
HSIC
$9.48B
| $1.49M | ﹤0.01% |
25,518
+24,181
| +1,809% | +$1.35M |
|
1087
Comtech Telecommunications
CMTL
$45.5M
| $1.49M | ﹤0.01% |
88,174
+80,606
| +1,065% | +$1.36M |
|
|
CLGX
1088
DELISTED
Corelogic, Inc.
CLGX
| $1.49M | ﹤0.01% |
22,157
-26,721
| -55% | -$1.19M |
|
1089
Kilroy Realty
KRC
$4B
| $1.49M | ﹤0.01% |
25,321
+695
| +3% | +$42.1K |
|
1090
Nu Skin
NUS
$224M
| $1.48M | ﹤0.01% |
38,839
-82,566
| -68% | -$2.65M |
|
1091
MKS Inc
MKSI
$16.2B
| $1.48M | ﹤0.01% |
13,079
-637
| -5% | -$63.4K |
|
|
CNSL
1092
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.48M | ﹤0.01% |
218,815
+61,006
| +39% | +$358K |
|
1093
Encompass Health
EHC
$12.1B
| $1.47M | ﹤0.01% |
29,845
-1,472
| -5% | -$79.4K |
|
1094
EOG Resources
EOG
$76.3B
| $1.45M | ﹤0.01% |
28,615
-460,286
| -94% | -$22.3M |
|
|
DRTT
1095
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
| $1.45M | ﹤0.01% |
1,200,000
| – | – |
|
1096
SLM Corp
SLM
$4.7B
| $1.45M | ﹤0.01% |
206,156
+92,607
| +82% | +$692K |
|
1097
New York Times
NYT
$11.3B
| $1.45M | ﹤0.01% |
34,419
-1,753
| -5% | -$63.8K |
|
1098
Globe Life
GL
$13.2B
| $1.44M | ﹤0.01% |
19,410
+8,395
| +76% | +$637K |
|
1099
NewMarket
NEU
$8.18B
| $1.44M | ﹤0.01% |
3,597
+1,741
| +94% | +$718K |
|
1100
Cognizant
CTSH
$27.9B
| $1.43M | ﹤0.01% |
25,204
+6,989
| +38% | +$375K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.